Details for New Drug Application (NDA): 021918
✉ Email this page to a colleague
The generic ingredient in CETRAXAL is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 021918
| Tradename: | CETRAXAL |
| Applicant: | Lab Salvat |
| Ingredient: | ciprofloxacin hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OTIC | Strength | EQ 0.2% BASE | ||||
| Approval Date: | May 1, 2009 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
